These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22104146)

  • 21. Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors.
    Ikegashira K; Oka T; Hirashima S; Noji S; Yamanaka H; Hara Y; Adachi T; Tsuruha J; Doi S; Hase Y; Noguchi T; Ando I; Ogura N; Ikeda S; Hashimoto H
    J Med Chem; 2006 Nov; 49(24):6950-3. PubMed ID: 17125247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.
    Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.
    Wang G; Zhang L; Wu X; Das D; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Buckman BO; Kossen K; Seiwert SD; Beigelman L
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4484-7. PubMed ID: 19497737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
    May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of pentacyclic compounds as potent inhibitors of hepatitis C virus NS5B RNA polymerase.
    Habermann J; Capitò E; Ferreira Mdel R; Koch U; Narjes F
    Bioorg Med Chem Lett; 2009 Feb; 19(3):633-8. PubMed ID: 19109015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The discovery and structure-activity relationships of pyrano[3,4-b]indole-based inhibitors of hepatitis C virus NS5B polymerase.
    Jackson RW; LaPorte MG; Herbertz T; Draper TL; Gaboury JA; Rippin SR; Patel R; Chunduru SK; Benetatos CA; Young DC; Burns CJ; Condon SM
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3227-31. PubMed ID: 21550237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase.
    Cummings MD; Lin TI; Hu L; Tahri A; McGowan D; Amssoms K; Last S; Devogelaere B; Rouan MC; Vijgen L; Berke JM; Dehertogh P; Fransen E; Cleiren E; van der Helm L; Fanning G; Nyanguile O; Simmen K; Van Remoortere P; Raboisson P; Vendeville S
    J Med Chem; 2014 Mar; 57(5):1880-92. PubMed ID: 24144360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syntheses and initial evaluation of a series of indolo-fused heterocyclic inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus.
    Zheng X; Hudyma TW; Martin SW; Bergstrom C; Ding M; He F; Romine J; Poss MA; Kadow JF; Chang CH; Wan J; Witmer MR; Morin P; Camac DM; Sheriff S; Beno BR; Rigat KL; Wang YK; Fridell R; Lemm J; Qiu D; Liu M; Voss S; Pelosi L; Roberts SB; Gao M; Knipe J; Gentles RG
    Bioorg Med Chem Lett; 2011 May; 21(10):2925-9. PubMed ID: 21486696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.
    Wang G; Lei H; Wang X; Das D; Hong J; Mackinnon CH; Coulter TS; Montalbetti CA; Mears R; Gai X; Bailey SE; Ruhrmund D; Hooi L; Misialek S; Rajagopalan PT; Cheng RK; Barker JJ; Felicetti B; Schönfeld DL; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4480-3. PubMed ID: 19500983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
    Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrahydrobenzothiophene inhibitors of hepatitis C virus NS5B polymerase.
    Laporte MG; Lessen TA; Leister L; Cebzanov D; Amparo E; Faust C; Ortlip D; Bailey TR; Nitz TJ; Chunduru SK; Young DC; Burns CJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):100-3. PubMed ID: 16260131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase.
    Ruebsam F; Sun Z; Ayida BK; Webber SE; Zhou Y; Zhao Q; Kissinger CR; Showalter RE; Shah AM; Tsan M; Patel R; Lebrun LA; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Kirkovsky L
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5002-5. PubMed ID: 18722768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
    Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors.
    Chen KX; Lesburg CA; Vibulbhan B; Yang W; Chan TY; Venkatraman S; Velazquez F; Zeng Q; Bennett F; Anilkumar GN; Duca J; Jiang Y; Pinto P; Wang L; Huang Y; Selyutin O; Gavalas S; Pu H; Agrawal S; Feld B; Huang HC; Li C; Cheng KC; Shih NY; Kozlowski JA; Rosenblum SB; Njoroge FG
    J Med Chem; 2012 Mar; 55(5):2089-101. PubMed ID: 22247956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.
    Ruebsam F; Murphy DE; Tran CV; Li LS; Zhao J; Dragovich PS; McGuire HM; Xiang AX; Sun Z; Ayida BK; Blazel JK; Kim SH; Zhou Y; Han Q; Kissinger CR; Webber SE; Showalter RE; Shah AM; Tsan M; Patel RA; Thompson PA; Lebrun LA; Hou HJ; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Khandurina J; Brooks J; Okamoto E; Kirkovsky L
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6404-12. PubMed ID: 19818610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved replicon cellular activity of non-nucleoside allosteric inhibitors of HCV NS5B polymerase: from benzimidazole to indole scaffolds.
    Beaulieu PL; Gillard J; Bykowski D; Brochu C; Dansereau N; Duceppe JS; Haché B; Jakalian A; Lagacé L; LaPlante S; McKercher G; Moreau E; Perreault S; Stammers T; Thauvette L; Warrington J; Kukolj G
    Bioorg Med Chem Lett; 2006 Oct; 16(19):4987-93. PubMed ID: 16908138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons.
    Beaulieu PL; Gillard J; Jolicoeur E; Duan J; Garneau M; Kukolj G; Poupart MA
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3658-63. PubMed ID: 21550240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.
    Chan L; Das SK; Reddy TJ; Poisson C; Proulx M; Pereira O; Courchesne M; Roy C; Wang W; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Labrecque D; Bethell R; Hamel M; Courtemanche-Asselin P; L'Heureux L; David M; Nicolas O; Brunette S; Bilimoria D; Bédard J
    Bioorg Med Chem Lett; 2004 Feb; 14(3):793-6. PubMed ID: 14741291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.